Trials / Recruiting
RecruitingNCT05500391
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Randomized Phase II Trial Evaluating Compliance With Monitoring Conducted Either by a Hospital-based Physician in Person or by a Nurse in Remote Monitoring
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- Sponsor
- Centre Oscar Lambret · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).
Detailed description
The primary objective of this study is to compare 2-year compliance with the personalized post-treatment surveillance plan between the two arms. The secondary objectives are to compare between the two arms : * Long-term compliance (5-year follow-up) * Use of care * Oncological events and their management * Supportive care needs The exploratory objectives are to : * Evaluate the costs in terms of medical transportation * Evaluate and compare patients' satisfaction and psychological well-being (in terms of anxiety/depression) * Evaluate the homogeneity of the impact of the intervention according to covariates (gender, tumor pathology, occupational status, and center) * Evaluate the reasons for recruitment failures
Conditions
- Stage I Testicular Seminoma
- Stage I Testicular Nonseminomatous Germ Cell Tumor
- Gastrointestinal Stromal Tumors
- Ovarian Germ Cell Tumor
- Adenocarcinoma, Clear Cell
- Borderline Ovarian Tumor
- Sex Cord-Stromal Tumor
- Mucinous Adenocarcinoma of Ovary
- Carcinoma, Small Cell
- Carcinosarcoma, Ovarian
- Serous Tumor of Ovary
- Glioma
- Neuroendocrine Tumors
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Oncological Follow-up | Post-cancer surveillance (including biological, clinical and imaging exams depending on the condition) |
Timeline
- Start date
- 2024-02-28
- Primary completion
- 2026-10-01
- Completion
- 2032-07-01
- First posted
- 2022-08-15
- Last updated
- 2026-03-18
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05500391. Inclusion in this directory is not an endorsement.